Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03775577 · ClinicalTrials.gov registry record
Exercise Intolerance in Heart Failure
A clinical trial of Heart Failure With Normal Ejection Fraction, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- 130
- Enrollment target
- 1
- Study location
NCT03775577: Recruiting study of Heart Failure With Normal Ejection Fraction, sponsored by Johns Hopkins University.
NCT03775577 is a study of Heart Failure With Normal Ejection Fraction that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 130 participants, below the 627-participant average among 10 other Heart Failure With Normal Ejection Fraction trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03775577, a study of Heart Failure With Normal Ejection Fraction, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are studying whether metabolic abnormalities in cardiac and skeletal muscle in patients with heart failure with preserved ejection fraction (HFpEF) are associated with debilitating exercise intolerance.
Primary Outcome
Maximal oxidative capacity of leg muscle measured by 31P Magnetic Resonance Spectroscopy (MRS)
Conditions Studied
Study Locations (1)
Maryland
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2017-04-01 |
| Est. Completion | 2027-08 |
What NCT03775577 shows while recruiting
NCT03775577 is an observational study that tracks outcomes without assigning an intervention. The registered 130 participants enrollment target is mid-sized for trials with a published cap, below the 627-participant average among 10 other Heart Failure With Normal Ejection Fraction trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Heart Failure With Normal Ejection Fraction appearing as the primary indexed condition, and to 0 interventions.
NCT03775577 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT03775577 about?
NCT03775577 is a clinical study titled "Exercise Intolerance in Heart Failure". The investigators are studying whether metabolic abnormalities in cardiac and skeletal muscle in patients with heart failure with preserved ejection fraction (HFpEF) are associated with debilitating exercise intolerance.
What is the current status of trial NCT03775577?
This trial is currently recruiting. The enrollment target is 130 participants. The study started on 2017-04-01. Estimated completion is 2027-08.
What conditions does trial NCT03775577 study?
This clinical trial studies the following conditions: Heart Failure With Normal Ejection Fraction.
Who is sponsoring clinical trial NCT03775577?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03775577 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure With Normal Ejection Fraction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03775577's enrollment target sits among peer trials
130 5th of 10 higher than 6 of 10 other Heart Failure With Normal Ejection Fraction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure With Normal Ejection Fraction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
New Orleans Pulmonary Hypertension Biobank
RECRUITING
-
Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure
RECRUITING
-
Imaging Histone Deacetylase in the Heart
RECRUITING · NA
-
Ablation Versus Medical Management of Atrial Fibrillation in HFpEF
ACTIVE NOT RECRUITING · NA
-
Circulating RNAs in Acute Congestive Heart Failure
ACTIVE NOT RECRUITING
-
Treatment of HFpEF With Nitrate Supplement
COMPLETED · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492036 · 130 participants
Long-Term Follow-Up of Recipient of Gene Transfer Research
- NCT01631617 · 130 participants · Phase 2
Effects of Treatments on Atopic Dermatitis
- NCT02368041 · 130 participants
Utility of Thenar Near Infrared Spectroscopy (NIRS) in Pediatric Patients With Heart Failure
- NCT02604277 · 130 participants · NA
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI